More than fishing for a cure: The promises and pitfalls of high throughput cancer cell line screens
- 1 November 2018
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 191, 178-189
Abstract
No abstract availableKeywords
Funding Information
- University of Chicago (T32 CA009594)
- Avon Progress for Women
- NIH
- NIGMS (K08GM089941, U01GM61393)
- NIH
- NCI (R21CA139278, 1R01CA204856-01A1)
This publication has 52 references indexed in Scilit:
- Annotating Cancer Variants and Anti-Cancer Therapeutics in ReactomeCancers, 2012
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- BioProject and BioSample databases at NCBI: facilitating capture and organization of metadataNucleic Acids Research, 2011
- Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancerProceedings of the National Academy of Sciences, 2011
- Emerging ethnic differences in lung cancer therapyBritish Journal of Cancer, 2008
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- A census of human cancer genesNature Reviews Cancer, 2004
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000